Smith & Nephew/SNN

$26.42

-0.33%
-
1D1W1MYTD1YMAX

About Smith & Nephew

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. Its segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that help surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.

Ticker

SNN

Sector

Healthcare

Trading on

NYSE

Industry

Medical Equipment & Supplies

CEO

Deepak Nath

Employees

19,000

Headquarters

Watford, United Kingdom

Smith & Nephew Metrics

BasicAdvanced
$11.56B
Market cap
52.90
P/E ratio
$0.50
EPS
0.73
Beta
-
Dividend rate
2.84%
Dividend yield

What the Analysts think about Smith & Nephew

Analyst Ratings

Majority rating from 4 analysts.
Buy

Price Targets

Average projection from 3 analysts.
19.87% upside
High $34.00
Low $28.00
$26.42
Current price
$31.67
Average price target

Smith & Nephew Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
6.29% profit margin
QuarterlyAnnual
Q2 23
QoQ growth
Revenue
$2.73B
4.55%
Net income
$172M
273.91%
Profit margin
6.29%
259.43%

Smith & Nephew Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 29.46%
QuarterlyAnnual
Q2 22
Q4 22
Q2 23
Q4 23
Q2 24
Actual
$0.76
$0.88
$0.70
$0.96
-
Expected
$0.80
$0.80
$0.58
$0.74
$0.86
Surprise
-5%
10%
20.34%
29.46%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
ADR

Upcoming events

Buy or sell Smith & Nephew stock

Buy or sell Smith & Nephew stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing